does retatrutide lower a1c Retatrutide: A Promising Option for Non-Diabetic Weight Loss in Clinical Trials RETATRUTIDE: A Medication for Diabetes

[2] [11] The American Diabetes Association recommends specific GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk

Product packaging and label may appear different than image shown.

This study also suggested a potential regulatory role of GLP-1R activation in placental development (21)

Target Engagement Retatrutide engages GLP 1R, GIPR, and GCGR through direct peptide receptor binding that mimics the interaction of endogenous incretin and glucagon peptides

Endocrinology 139 , 40044007 (1998)

The visceral fat loss guide explores the relationship between liver fat and overall metabolic health in more detail